Table 2 of Paine, Mol Vis 2017; 23:356-363.

Table 2. Distribution of growth factors (VEGF) and its receptors among cases and controls.

Study phenotype variables Non diabetic control (n=22) Diabetic Control
(n=20) Diabetic Retinopathy
(n=81) P value
VEGF165a (pg/ml) 108.9±39.9 123.6±45.09 208.5±93.23 <0.0001*
VEGF165b
(pg/ml) 26.75±14.35 45.94±22.86 56.27±33.08 0.0002*
VEGF165a-b
(pg/ml) 52.16±40.06 61.38±42.54 157.70±101.2 <0.0001*
VEGFR1
(ng/ml) 26.97±10.38 21.00±16.75 19.81±16.14 0.15
VEGFR2
(pg/ml) 26.75±14.35 49.94±22.86 56.27±33.08 0.002*
VEGFR3
(pg/ml) 23.45±19.99 17.34±15.02 17.68±14.46 0.3
CMT (um) - 213±102 319±181 <0.0001*

Data presented in Mean±SD among the study groups. *p value significant *after multiple testing correction (Bonferroni’s correction). Adjusted p value after correction was 0.007.

Paine, Mol Vis 2017; 23:356-363. http://www.molvis.org/molvis/v23/356

©2017 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535